ArticleAnnals of nuclear medicine2021

Phase I clinical study of NMB58, a novel positron emission tomography (PET)-myocardial perfusion imaging tracer, conducted to evaluate its safety and pharmacokinetics in Japanese healthy adult males.

Mirai Kawano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.